Pharmazz, Inc.
Clinical trials sponsored by Pharmazz, Inc., explained in plain language.
-
Breakthrough drug trial aims to save lives from fatal blood loss shock
Disease control Recruiting nowThis study is testing the safety and effectiveness of a new drug called LYFAQUIN (centhaquine citrate) for people with life-threatening shock caused by severe blood or fluid loss. About 400 adult patients with very low blood pressure will receive LYFAQUIN in addition to all stand…
Phase: PHASE4 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated Apr 02, 2026 01:11 UTC
-
New hope for babies with Birth-Related brain damage
Disease control Recruiting nowThis study is testing whether a new drug called sovateltide can help newborns who have brain injury from not getting enough oxygen during or around birth. The drug aims to protect brain cells and promote repair. Researchers will compare sovateltide to a placebo in 40 babies to se…
Phase: PHASE2 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated Apr 02, 2026 01:11 UTC
-
New drug trial aims to boost brain repair after stroke
Disease control Recruiting nowThis study is testing an investigational drug called sovateltide, given alongside standard care, to see if it can help people recover better after a sudden ischemic stroke. It aims to improve brain repair and help patients regain more function and independence. The trial will enr…
Phase: PHASE3 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug aims to help stroke victims walk and talk again
Disease control Recruiting nowThis study is testing if an investigational drug called sovateltide can help the brain heal and improve recovery after a stroke. It will be given by IV along with standard stroke care to 160 adults who have recently had an ischemic stroke. Researchers will compare the recovery of…
Phase: PHASE4 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC